Identification of MGB1 as a Marker in the Differential Diagnosis of Lung Tumors in Patients With a History of Breast Cancer by Analysis of Publicly Available SAGE Data

Journal of Molecular Diagnostics - United States
doi 10.1016/s1525-1578(10)60495-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Analysis of Publicly Available Business E-Data in Slovakia

EAI Endorsed Transactions on Smart Cities
2018English

Diagnosis of Cancer as a Marker

The Primary Care Companion to The Journal of Clinical Psychiatry
2007English

High Expression of EZH2 as a Marker for the Differential Diagnosis of Malignant and Benign Myogenic Tumors

Scientific Reports
Multidisciplinary
2018English

SETD3 Acts as a Prognostic Marker in Breast Cancer Patients and Modulates the Viability and Invasion of Breast Cancer Cells

Scientific Reports
Multidisciplinary
2020English

Demethylation of Urokinase Promoter as a Prognostic Marker in Patients With Breast Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2004English

Breast Cancer Profile Among Patients With a History of Chemoprevention

International Journal of Breast Cancer
Cancer ResearchOncologyPharmacology
2016English

The Trans-Data Study: Aims and Design of a Translational Breast Cancer Prognostic Marker Identification Study

Diagnostic and Prognostic Research
2019English

CREATE-X a Role for Capecitabine in Early-Stage Breast Cancer: An Analysis of Available Data

npj Breast Cancer
OncologyRadiologyNuclear MedicinePharmacologyImaging
2017English

Chitotriosidase, a Marker of Innate Immunity, Is Elevated in Patients With Primary Breast Cancer

Cancer Biomarkers
MedicineCancer ResearchOncologyGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy